S. Schuster

发表

Effect of 1-(1-naphthylmethyl)-piperazine, a novel putative efflux pump inhibitor, on antimicrobial drug susceptibility in clinical isolates of Escherichia coli.

W. Kern, Petra Steinke, A. Schumacher, 2006, The Journal of antimicrobial chemotherapy.

A continuous sirtuin activity assay without any coupling to enzymatic or chemical reactions

C. Steegborn, M. Schutkowski, C. Kambach, 2016, Scientific Reports.

Altered spectrum of multidrug resistance associated with a single point mutation in the Escherichia coli RND-type MDR efflux pump YhiV (MdtF).

W. Kern, S. Schuster, J. Bohnert, 2007, The Journal of antimicrobial chemotherapy.

Detection of High-Level Rifaximin Resistance in Enteric Bacteria by Agar Screen.

W. Kern, S. Schuster, H. Gölz, 2019, Microbial drug resistance.

Synthesis and in vitro biochemical evaluation of oxime bond-linked daunorubicin–GnRH-III conjugates developed for targeted drug delivery

L. Buday, G. Mező, S. Schuster, 2018, Beilstein journal of organic chemistry.

Development and Biochemical Characterization of Self-Immolative Linker Containing GnRH-III-Drug Conjugates

G. Mező, S. Schuster, I. Neundorf, 2022, International journal of molecular sciences.

Safety and immunogenicity of an mRNA-lipid nanoparticle vaccine candidate against SARS-CoV-2

N. Klopp, P. Kremsner, M. Fotin‐Mleczek, 2021, Wiener klinische Wochenschrift.

Novel Piperazine Arylideneimidazolones Inhibit the AcrAB-TolC Pump in Escherichia coli and Simultaneously Act as Fluorescent Membrane Probes in a Combined Real-Time Influx and Efflux Assay

J. Handzlik, T. Karcz, K. Kieć‐Kononowicz, 2016, Antimicrobial Agents and Chemotherapy.

Determination of Real-Time Efflux Phenotypes in Escherichia coli AcrB Binding Pocket Phenylalanine Mutants Using a 1,2′-Dinaphthylamine Efflux Assay

W. Kern, S. Schuster, J. Bohnert, 2011, PloS one.

Evidence of a Substrate-Discriminating Entrance Channel in the Lower Porter Domain of the Multidrug Resistance Efflux Pump AcrB

W. Kern, S. Schuster, M. Vávra, 2016, Antimicrobial Agents and Chemotherapy.

Random Mutagenesis of the Multidrug Transporter AcrB from Escherichia coli for Identification of Putative Target Residues of Efflux Pump Inhibitors

W. Kern, S. Schuster, J. Bohnert, 2014, Antimicrobial Agents and Chemotherapy.

Exploring the Contribution of the AcrB Homolog MdtF to Drug Resistance and Dye Efflux in a Multidrug Resistant E. coli Isolate

W. Kern, S. Schuster, M. Vávra, 2021, Antibiotics.

Efflux inhibition by selective serotonin reuptake inhibitors in Escherichia coli.

W. Kern, S. Schuster, J. Bohnert, 2011, The Journal of antimicrobial chemotherapy.

Site-Directed Mutagenesis Reveals Putative Substrate Binding Residues in the Escherichia coli RND Efflux Pump AcrB

M. Seeger, W. Kern, S. Schuster, 2008, Journal of bacteriology.

Improved In Vivo Anti-Tumor and Anti-Metastatic Effect of GnRH-III-Daunorubicin Analogs on Colorectal and Breast Carcinoma Bearing Mice

G. Mező, C. Steinkühler, S. Schuster, 2019, International journal of molecular sciences.

Enhanced In Vitro Antitumor Activity of GnRH-III-Daunorubicin Bioconjugates Influenced by Sequence Modification

L. Buday, G. Mező, S. Schuster, 2018, Pharmaceutics.

Limited Multidrug Resistance Efflux Pump Overexpression among Multidrug-Resistant Escherichia coli Strains of ST131

J. Rossen, W. Kern, S. Schuster, 2021, Antimicrobial Agents and Chemotherapy.

Efflux-Mediated Resistance to New Oxazolidinones and Pleuromutilin Derivatives in Escherichia coli with Class Specificities in the Resistance-Nodulation-Cell Division-Type Drug Transport Pathways

W. Kern, S. Schuster, M. Vávra, 2019, Antimicrobial Agents and Chemotherapy.

Proof of an Outer Membrane Target of the Efflux Inhibitor Phe-Arg-β-Naphthylamide from Random Mutagenesis

J. Rossen, W. Kern, S. Schuster, 2019, Molecules.

University of Groningen Proof of an Outer Membrane Target of the Efflux Inhibitor Phe-Arg-β-Naphthylamide from Random Mutagenesis Schuster,

J. Rossen, W. Kern, S. Schuster, 2019 .

Contribution of AcrAB-TolC to multidrug resistance in an Escherichia coli sequence type 131 isolate.

J. Rossen, Y. Matsumura, W. Kern, 2017, International journal of antimicrobial agents.

Pimozide Inhibits the AcrAB-TolC Efflux Pump in Escherichia coli

W. Kern, S. Schuster, J. Bohnert, 2013, The open microbiology journal.

Site-Directed Mutagenesis Reveals Putative Substrate Binding Residues in the Escherichia coli RND Efﬂux Pump AcrB (cid:1)

M. Seeger, W. Kern, S. Schuster, 2008 .

Protein engineering of a stable and potent anti-inflammatory IL-37-Fc fusion with enhanced therapeutic potential.

J. Whisstock, A. Bujotzek, M. Nold, 2021, Cell chemical biology.

New Topoisomerase Inhibitors: Evaluating the Potency of Gepotidacin and Zoliflodacin in Fluoroquinolone-Resistant Escherichia coli upon tolC Inactivation and Differentiating Their Efflux Pump Substrate Nature

J. Rossen, W. Kern, S. Schuster, 2020, Antimicrobial Agents and Chemotherapy.

Anthropogenic Causes, Mechanisms and Effects of Upper Pliocene and Quaternary Extinctinctions of Large Vertebrates

S. Schuster, Wilhelm Schüe, 2000 .

Site-Directed Mutagenesis Reveals Amino Acid Residues in the Escherichia coli RND Efflux Pump AcrB That Confer Macrolide Resistance

W. Kern, S. Schuster, J. Bohnert, 2008, Antimicrobial Agents and Chemotherapy.

The role of Pd2+/Pd0 in hydrogenation by [Pd(2-pymo)2]n: an X-ray absorption and IR spectroscopic study.

M. Bauer, E. Klemm, S. Schuster, 2012, Chemistry.

Comparative reassessment of AcrB efflux inhibitors reveals differential impact of specific pump mutations on the activity of potent compounds

S. Schuster, Martina Vavra, Winfried V. Kern, 2024, Microbiology spectrum.